Neffy nasal spray shows comparable efficacy to IM epinephrine for type I allergic reactions, with 92.3% symptom resolution after 1 dose.

Intranasal epinephrine was developed to provide needle-free, on-demand rescue therapy for CSU flares, addressing limitations of systemic options such as glucocorticoids and their adverse-effect burden ...

Future Cardiol. 2010;6(4):473-482. Epinephrine administration has been advocated in resuscitation for decades and forms a key component of published guidelines. Its usage is based chiefly on animal ...

Following the conference call, a recording of the webcast will be available on Nasus Pharma’s investor relations website at https://ir.nasuspharma.com/investors/events/.

Credit: ARS Pharma. Neffy is supplied as a single-dose (2mg of epinephrine) nasal spray that is administered into 1 nostril. With regard to cardiovascular effects, increases in blood pressure and ...

Epinephrine improves ROSC in cardiac arrest but does not increase favorable neurologic recovery, raising ethical and ...

DALLAS – April 22, 2004 – Medical personnel attempting to resuscitate a child in cardiac arrest should abide by epinephrine dosing levels outlined in the Pediatric Advanced Life Support (PALS) ...

The Food and Drug Administration approved the first needle-free alternative to the EpiPen on Friday, a single-use epinephrine nasal spray for the emergency treatment of allergic reactions, including ...

Among children with in-hospital cardiac arrest with an initial nonshockable heart rhythm who received epinephrine (adrenaline), delay in administration of epinephrine was associated with a decreased ...

A committee of the Food and Drug Administration's outside advisers voted Thursday in favor of an epinephrine nasal spray product, clearing a key hurdle for what could soon be the first needle-free ...